To evaluate whether the potential immunogenic modulation of high doses of RT could induce an anti-tumor “vaccine-like” effect, we monitored the presence and the amount of circulating CD4+ and CD8+ T cell responses against known epitopes derived from the MPM-associated antigens mesothelin and WT-1 before and 1 month after RT. Here, CD8A is linked to neoplasm.